[
    [
        {
            "time": "",
            "original_text": "238亿主力资金近三日撤出全A(非陆股通重仓前100)概念股",
            "features": {
                "keywords": [
                    "主力资金",
                    "撤出",
                    "全A",
                    "非陆股通",
                    "重仓前100",
                    "概念股"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全A股",
                    "概念股"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "238亿主力资金近三日撤出全A(非陆股通重仓前100)概念股",
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "融资客青睐8股，东诚药业买入占比高达48.55%",
            "features": {
                "keywords": [
                    "融资客",
                    "青睐",
                    "东诚药业",
                    "买入占比",
                    "48.55%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "个股",
                    "东诚药业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "融资客青睐8股，东诚药业买入占比高达48.55%",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]